Ursula Matulonis
MD
Chief, Division of Gynecologic Oncology
👥Biography 个人简介
Ursula Matulonis leads gynecologic oncology at Dana-Farber and has directed numerous trials of olaparib and niraparib in recurrent and platinum-sensitive ovarian cancer. She co-led studies defining maintenance PARP inhibitor use after front-line platinum. Her work shaped current NCCN guideline recommendations.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Ursula Matulonis 的研究动态
Follow Ursula Matulonis's research updates
留下邮箱，当我们发布与 Ursula Matulonis（Dana-Farber Cancer Institute / Harvard Medical School）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment